Winton Group LTD Neogenomics Inc Transaction History

Winton Group LTD

$1.72 Billion
Q2 2025

A detailed history of Winton Group LTD transactions in Neogenomics Inc stock. As of the latest transaction made, Winton Group LTD holds 58,620 shares of NEO stock, worth $609,648. This represents 0.02% of its overall portfolio holdings.

Number of Shares

58,620

Previous 78,495 25.32%

Holding current value

$609,648

Previous $744,000 42.47%

% of portfolio

0.02%

Previous 0.05%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.4 - $10.27 $127,200 - $204,116	-19,875 Reduced 25.32%	58,620 $428,000
Q1 2025 May 15, 2025	BUY	$9.09 - $18.61 $713,519 - $1.46 Million	78,495 New	78,495 $744,000
Q3 2024 Nov 12, 2024	BUY	$13.4 - $17.73 $341,566 - $451,937	25,490 New	25,490 $375,000
Q3 2023 Nov 13, 2023	BUY	$12.15 - $17.85 $131,414 - $193,065	10,816 New	10,816 $133,000
Q3 2019 Nov 08, 2019	SELL	$19.12 - $26.24 $289,993 - $397,982	-15,167 Closed	0 $0
Q2 2019 Jul 08, 2019	SELL	$19.57 - $24.1 $293,256 - $361,138	-14,985 Reduced 49.7%	15,167 $333,000
Q1 2019 May 13, 2019	BUY	$12.14 - $20.46 $10,658 - $17,963	878 Added 3.0%	30,152 $617,000
Q4 2018 Feb 05, 2019	BUY	$11.24 - $18.5 $42,082 - $69,264	3,744 Added 14.67%	29,274 $369,000
Q3 2018 Nov 02, 2018	BUY	$12.5 - $15.38 $60,825 - $74,839	4,866 Added 23.55%	25,530 $0
Q2 2018 Aug 20, 2018	SELL	$7.99 - $14.05 $165,968 - $291,846	-20,772 Reduced 50.13%	20,664 $0
Q1 2018 May 21, 2018	BUY	$7.23 - $8.76 $299,582 - $362,979	41,436 New	41,436 $0

Others Institutions Holding NEO

# of Institutions

303

Shares Held

127M

Call Options Held

1.17M

Put Options Held

297K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.31B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account